YARROW BIOSCIENCE, INC. Increase (Decrease) in Accounts Receivable
YARROW BIOSCIENCE, INC. (YARW) reported Increase (Decrease) in Accounts Receivable of -$786.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2020-03-03
- YARROW BIOSCIENCE, INC. increase (decrease) in accounts receivable for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- YARROW BIOSCIENCE, INC. increase (decrease) in accounts receivable for the quarter ending 2018-09-30 was -$93.00K.
- YARROW BIOSCIENCE, INC. increase (decrease) in accounts receivable for the quarter ending 2018-06-30 was -$141.00K.
- YARROW BIOSCIENCE, INC. increase (decrease) in accounts receivable for the quarter ending 2018-03-31 was -$552.00K.
- YARROW BIOSCIENCE, INC. increase (decrease) in accounts receivable for fiscal 2018 was -$786.00K, a 200.00% decline from fiscal 2017.
- YARROW BIOSCIENCE, INC. increase (decrease) in accounts receivable for fiscal 2017 was $786.00K.
- YARROW BIOSCIENCE, INC. increase (decrease) in accounts receivable for fiscal 2016 was $0.00.
- YARROW BIOSCIENCE, INC. increase (decrease) in accounts receivable for fiscal 2015 was $0.00.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | -$93.00K derived: sum of 2 quarters · filed 2020-03-03 | -$234.00K derived: sum of 3 quarters · filed 2020-03-03 | -$786.00K 10-K · filed 2020-03-03 |
| 2018-09-30 | -$93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$234.00K derived: sum of 2 quarters · filed 2019-10-31 | -$786.00K 10-Q · filed 2019-10-31 | -$460.00K derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-06-30 | -$141.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$693.00K 10-Q · filed 2019-08-01 | -$367.00K derived: sum of 3 quarters · filed 2020-03-03 | |
| 2018-03-31 | -$552.00K 10-Q · filed 2019-05-02 | -$226.00K derived: sum of 2 quarters · filed 2020-03-03 | ||
| 2017-12-31 | $326.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $786.00K 10-K · filed 2020-03-03 | ||
| 2017-09-30 | $460.00K 10-Q · filed 2018-11-07 | |||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |